Selective Interaction of the Antimicrobial Peptide RKW with Bacterial Lipid Bilayers: A Biophysical Approach

Alessandra Porritiello1, Bruna Agrillo1, Marta Gogliettino1

  • 1Institute of Biosciences and BioResources (IBBR)-National Research Council (-CNR), Naples 80131, Italy.

ACS Omega
|March 2, 2026
PubMed

Insights

A novel antimicrobial peptide, RKW, selectively targets bacterial membranes over human cells, offering a promising new approach for antibiotics. Its mechanism involves membrane disruption with low host cell toxicity, confirmed in vivo.

Area of Science:

  • Biophysics
  • Antimicrobial Peptides
  • Membrane Biology

Background:

  • Antimicrobial peptides (AMPs) show potential against multidrug-resistant bacteria but face limitations due to host cell toxicity.
  • Understanding AMP-membrane interactions is crucial for developing safer therapeutics.

Purpose of the Study:

  • Investigate the interaction of the designed AMP, RKW, with model membranes.
  • Determine RKW's selectivity and mechanism of action against bacterial versus eukaryotic membranes.

Main Methods:

  • Utilized model lipid vesicles mimicking prokaryotic and eukaryotic membranes.
  • Employed fluorescence spectroscopy, quenching experiments, and dynamic light scattering (DLS).
  • Conducted toxicological assessments using *Caenorhabditis elegans*.

Main Results:

  • RKW demonstrated strong preference for negatively charged bacterial membranes, especially Gram-negative models.
  • Peptide localized at the membrane interface, likely parallel to the bilayer.
  • RKW induced significant carboxyfluorescein leakage from bacterial models, indicating membrane permeabilization.
  • In vivo studies showed no adverse effects of RKW on *C. elegans*.

Conclusions:

  • RKW exhibits selective membrane targeting driven by electrostatic interactions.
  • The peptide effectively permeabilizes bacterial membranes with minimal host cell toxicity.
  • RKW presents potential as a targeted antimicrobial agent with a favorable safety profile.